These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29330362)

  • 1. Dynamic modelling of the mTOR signalling network reveals complex emergent behaviours conferred by DEPTOR.
    Varusai TM; Nguyen LK
    Sci Rep; 2018 Jan; 8(1):643. PubMed ID: 29330362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1.
    Ghomlaghi M; Yang G; Shin SY; James DE; Nguyen LK
    PLoS Comput Biol; 2021 Sep; 17(9):e1008513. PubMed ID: 34529665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoproteome Analysis Reveals Estrogen-ER Pathway as a Modulator of mTOR Activity Via DEPTOR.
    Cuesta R; Gritsenko MA; Petyuk VA; Shukla AK; Tsai CF; Liu T; McDermott JE; Holz MK
    Mol Cell Proteomics; 2019 Aug; 18(8):1607-1618. PubMed ID: 31189691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma.
    Yao H; Tang H; Zhang Y; Zhang QF; Liu XY; Liu YT; Gu WT; Zheng YZ; Shang HB; Wang Y; Huang JY; Wei YX; Zhang X; Zhang J; Wu ZB
    Cancer Lett; 2019 Sep; 459():135-144. PubMed ID: 31176743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression.
    Maity S; Bera A; Ghosh-Choudhury N; Das F; Kasinath BS; Choudhury GG
    Exp Cell Res; 2018 Mar; 364(1):5-15. PubMed ID: 29397070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR.
    Zhao L; Wang X; Yu Y; Deng L; Chen L; Peng X; Jiao C; Gao G; Tan X; Pan W; Ge X; Wang P
    J Biol Chem; 2018 Mar; 293(13):4883-4892. PubMed ID: 29382726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace.
    Heimhalt M; Berndt A; Wagstaff J; Anandapadamanaban M; Perisic O; Maslen S; McLaughlin S; Yu CW; Masson GR; Boland A; Ni X; Yamashita K; Murshudov GN; Skehel M; Freund SM; Williams RL
    Elife; 2021 Sep; 10():. PubMed ID: 34519269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry.
    Rogers-Broadway KR; Kumar J; Sisu C; Wander G; Mazey E; Jeyaneethi J; Pados G; Tsolakidis D; Klonos E; Grunt T; Hall M; Chatterjee J; Karteris E
    Int J Mol Med; 2019 Jan; 43(1):47-56. PubMed ID: 30387804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring novel and potent molecules for disrupting DEPTOR-mTOR interaction through structure-steered screening, extra-exactitude molecular docking, prime binding free energy estimation and voguish molecular dynamics.
    Shah BA; Ganai SA; Koul AM; Mohan S; Amin A; Wani Z; Majeed U; Rajamanikandan S; Farooq F; Malik FA; Shah NN; Qadri RA
    J Biomol Struct Dyn; 2022; 40(22):12037-12047. PubMed ID: 34431457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEPTOR at the Nexus of Cancer, Metabolism, and Immunity.
    Caron A; Briscoe DM; Richard D; Laplante M
    Physiol Rev; 2018 Jul; 98(3):1765-1803. PubMed ID: 29897294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of hepatic DEPTOR alters the metabolic transition to fasting.
    Caron A; Mouchiroud M; Gautier N; Labbé SM; Villot R; Turcotte L; Secco B; Lamoureux G; Shum M; Gélinas Y; Marette A; Richard D; Sabatini DM; Laplante M
    Mol Metab; 2017 May; 6(5):447-458. PubMed ID: 28462079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals.
    Chen X; Xiong X; Cui D; Yang F; Wei D; Li H; Shu J; Bi Y; Dai X; Gong L; Sun Y; Zhao Y
    Oncogene; 2020 Feb; 39(7):1557-1571. PubMed ID: 31685947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling.
    Csukasi F; Duran I; Barad M; Barta T; Gudernova I; Trantirek L; Martin JH; Kuo CY; Woods J; Lee H; Cohn DH; Krejci P; Krakow D
    Sci Transl Med; 2018 Sep; 10(459):. PubMed ID: 30232230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systems study reveals concurrent activation of AMPK and mTOR by amino acids.
    Dalle Pezze P; Ruf S; Sonntag AG; Langelaar-Makkinje M; Hall P; Heberle AM; Razquin Navas P; van Eunen K; Tölle RC; Schwarz JJ; Wiese H; Warscheid B; Deitersen J; Stork B; Fäßler E; Schäuble S; Hahn U; Horvatovich P; Shanley DP; Thedieck K
    Nat Commun; 2016 Nov; 7():13254. PubMed ID: 27869123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis of DEPTOR to Recognize Phosphatidic Acid Using its Tandem DEP Domains.
    Weng Z; Shen X; Zheng J; Liang H; Liu Y
    J Mol Biol; 2021 Jun; 433(13):166989. PubMed ID: 33865870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship study of small molecule inhibitors of the DEPTOR-mTOR interaction.
    Lee J; Shi Y; Vega M; Yang Y; Gera J; Jung ME; Lichtenstein A
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4714-4724. PubMed ID: 28916338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High glucose-stimulated enhancer of zeste homolog-2 (EZH2) forces suppression of deptor to cause glomerular mesangial cell pathology.
    Das F; Bera A; Ghosh-Choudhury N; Sataranatarajan K; Kamat A; Kasinath BS; Choudhury GG
    Cell Signal; 2021 Oct; 86():110072. PubMed ID: 34224844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways.
    Cho JH; Kim K; Kim SA; Park S; Park BO; Kim JH; Kim SY; Kwon MJ; Han MH; Lee SB; Park BC; Park SG; Kim JH; Kim S
    Cell Death Differ; 2021 Mar; 28(3):900-914. PubMed ID: 33110214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MNK Controls mTORC1:Substrate Association through Regulation of TELO2 Binding with mTORC1.
    Brown MC; Gromeier M
    Cell Rep; 2017 Feb; 18(6):1444-1457. PubMed ID: 28178522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.
    Shi Y; Daniels-Wells TR; Frost P; Lee J; Finn RS; Bardeleben C; Penichet ML; Jung ME; Gera J; Lichtenstein A
    Cancer Res; 2016 Oct; 76(19):5822-5831. PubMed ID: 27530328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.